218 related articles for article (PubMed ID: 30554718)
1. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
Dohar JE
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
3. Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children.
Faria J; Harb J; Hilton A; Yacobucci D; Pizzuto M
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2124-8. PubMed ID: 26478107
[TBL] [Abstract][Full Text] [Related]
4. Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study.
Shoval H; Levin J; Friel K; Kim H
J Pediatr Rehabil Med; 2019; 12(2):189-196. PubMed ID: 31227667
[TBL] [Abstract][Full Text] [Related]
5. BOTOX-A injection of salivary glands for drooling.
Alvarenga A; Campos M; Dias M; Melão L; Estevão-Costa J
J Pediatr Surg; 2017 Aug; 52(8):1283-1286. PubMed ID: 28277296
[TBL] [Abstract][Full Text] [Related]
6. Treatment of sialorrhea with botulinum toxin injections in pediatric patients less than three years of age.
Fan T; Frederick R; Abualsoud A; Sheyn A; McLevy-Bazzanella J; Thompson J; Akkus C; Wood J
Int J Pediatr Otorhinolaryngol; 2022 Jul; 158():111185. PubMed ID: 35594794
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
Chan KH; Liang C; Wilson P; Higgins D; Allen GC
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration.
Pena AH; Cahill AM; Gonzalez L; Baskin KM; Kim H; Towbin RB
J Vasc Interv Radiol; 2009 Mar; 20(3):368-73. PubMed ID: 19157908
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin injection to the salivary glands for the treatment of sialorrhea with chronic aspiration.
Raval TH; Elliott CA
Ann Otol Rhinol Laryngol; 2008 Feb; 117(2):118-22. PubMed ID: 18357835
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
Formeister EJ; Dahl JP; Rose AS
Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
13. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Chowdhury NA; Sewatsky ML; Kim H
Am J Phys Med Rehabil; 2017 Aug; 96(8):e151-e154. PubMed ID: 28081025
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A for children with salivary control problems.
Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
[TBL] [Abstract][Full Text] [Related]
15. Effect of recurrent onabotulinum toxin A injection into the salivary glands: An ultrasound measurement.
Cardona I; Saint-Martin C; Daniel SJ
Laryngoscope; 2015 Oct; 125(10):E328-32. PubMed ID: 26198624
[TBL] [Abstract][Full Text] [Related]
16. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.
Berweck S; Schroeder AS; Lee SH; Bigalke H; Heinen F
Dev Med Child Neurol; 2007 Jan; 49(1):62-4. PubMed ID: 17209979
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A in the treatment of sialorrhea.
Benson J; Daugherty KK
Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
[TBL] [Abstract][Full Text] [Related]
18. Does intraglandular injection of botulinum toxin improve pediatric sialorrhea?
Hughes A; Choi S
Laryngoscope; 2018 Jul; 128(7):1513-1514. PubMed ID: 29243262
[No Abstract] [Full Text] [Related]
19. The Experience of Treating Drooling with Repeated Botulinum Toxin Injections.
Sillanpää S; Sipilä M; Numminen J; Rautiainen M
ORL J Otorhinolaryngol Relat Spec; 2015; 77(6):333-8. PubMed ID: 26418063
[TBL] [Abstract][Full Text] [Related]
20. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands.
Jongerius PH; Joosten F; Hoogen FJ; Gabreels FJ; Rotteveel JJ
Laryngoscope; 2003 Jan; 113(1):107-11. PubMed ID: 12514392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
